Articles tagged with Cancer
A Phase III clinical trial showed that cancer patients who received specialized mental health support experienced lasting improvements in quality of life, reduced pain, depression, and fatigue. The intervention also led to lower risk of cardiovascular disease in family caregivers and substantial cost savings for the healthcare system.
A recent study published in the Journal of Veterinary Medicine found no significant correlation between canine lymphoma and proximity to environmental toxins. Researchers used data from Morris Animal Foundation's Golden Retriever Lifetime Study to map dog home addresses to radon zones and fracking wells, but did not find a link.
Researchers at the University of Southern Denmark have discovered a new function of the MYC protein, which plays a crucial role in cancer cell growth and division. The study shows that MYC can activate genes on both promoters and enhancers, driving cancer progression.
Researchers discovered that lung cancer cells can persist in the presence of cigarette smoke due to a protein pump called ABCG2, which clears damaging molecules from the cells. This mechanism could also contribute to resistance to pharmaceutical treatments in cancer cells.
Researchers developed protein-based microcapsules to enhance aptamer sensors, enabling direct detection of target molecules in biological samples. The system demonstrates robust protection against harmful proteins and simultaneous real-time sensing of multiple targets.
ISB researchers identify NKG2A-biased immune responses as protective against decreased inflammation and increased survival rates in various disease contexts. The study suggests potential therapeutic targets for modifying immune responses across diseases.
The European LeukemiaNet has published two-part guidelines for adult acute lymphoblastic leukemia treatment, covering diagnostics, prognostic factors, response assessments, and comprehensive management. These recommendations are based on a decade of systematic work by European experts, improving the prognosis of adult patients with ALL.
Children's Hospital Los Angeles will develop innovative stem cell approaches to treat children and adolescents with recurrent solid tumors using CAR T-cell therapy. The new approach targets B7H3, an immune marker on cancer cells, to identify and destroy them.
A study of 34,500 patients found racial and ethnic disparities in locally advanced rectal cancer treatment outcomes may be influenced by unidentified biological or social factors. Non-Hispanic Black patients were more likely to experience poorer outcomes.
A team of Rice University researchers has developed a platform for integrating DNA and RNA data from single-cell sequencing with greater speed and precision. The method, MaCroDNA, relies on a classical algorithm to identify matching pairs of data and outperformed state-of-the-art technologies in accuracy measurements.
Researchers have discovered that certain volatile compounds emitted by microbes and food can alter epigenetic states in neurons and other eukaryotic cells. Exposure to these compounds can slow down neurodegeneration and cancer, while also affecting plant growth and responses to stress.
The COVID-19 pandemic has widened socioeconomic disparities in death at home and access to specialized palliative care for cancer patients. The study found that these disparities were amplified, highlighting the need for equitable and consistent care access.
A team of researchers from Wayne State University and the Barbara Ann Karmanos Cancer Institute have received a five-year, $9.6 million grant to improve the identification and clinical management of hereditary and multiple primary cancers in African Americans. The study aims to overcome barriers to genetic testing in this population.
Researchers highlight difficulties in targeting metastatic tumors and propose two- and three-drug combinations to achieve effective tumor control. They also emphasize the need for simultaneous blocking of primary driving oncogene, evolving resistance mechanism, and secondary survival pathway.
A study published in JAMA Oncology revealed a significant decline in US cancer incidence during the first 10 months of the pandemic. The research found 134,395 potentially undiagnosed cancer cases between March and December 2020, highlighting an unusual drop in all-site cancer incidence.
A recent study by Cold Spring Harbor Laboratory researchers reveals that chronic stress can increase cancer's ability to spread. By mimicking chronic stress in mice with cancer, the team discovered that stress causes neutrophils to form sticky web-like structures called NETs, making body tissues more susceptible to metastasis.
Researchers developed a novel machine learning-based approach to analyze diffuse reflectance spectroscopy data, achieving higher accuracies and speeds than existing methods. The 'wavelength-independent regressor' model overcomes use-error limitations by incorporating diverse datasets, making it suitable for clinical settings.
Scientists at CeMM Research Center have discovered a new method to mark proteins for destruction, potentially treating diseases like cancer. The technique uses 'intramolecular bivalent glues' to alter the protein's surface, triggering targeted protein degradation via ubiquitin ligases.
Men with low sperm count or none have a higher risk of developing cancer, including at younger ages, compared to fertile men. Families of azoospermic men have a significantly increased risk of five cancers, while families of oligozoospermic men have a higher risk of colon, bone and joint, and testicular cancers.
Scientists have discovered that pancreatic cancer hijacks the brain-building protein Engrailed-1, leading to faster and deadlier metastasis. By targeting this aberrant protein, researchers may be able to develop personalized therapies and slow cancer progression.
A recent study has uncovered 145 genes crucial for genome stability, shedding light on genetic factors influencing human health over a lifespan. The research highlights the potential of SIRT inhibitors as a therapeutic pathway for cohesinopathies and other genomic disorders.
A team of physicists and veterinary scientists at Purdue University has developed a method to detect chemoresistance in cancer patients using biodynamic imaging (BDI). This technique measures the motions inside cancer cells and how they respond to chemotherapy, identifying patients who will not respond to treatment. The study shows pro...
A new study from the University of Ottawa proposes using vanoxerine, a drug initially developed for cocaine addiction, to potentially treat advanced colon cancer. Vanoxerine has been found to suppress cancer stem cell activity in colon cancer patients' tissues and tumours implanted in laboratory animals. The drug works by interfering w...
Researchers propose a novel augmentation regimen, IPIAD, combining five generic non-oncology drugs with standard chemotherapy for pancreatic ductal adenocarcinoma. The IPIAD regimen uses repurposed drugs like irbesartan and azithromycin to potentially slow disease growth and improve outcomes.
A small, wearable ultrasound sticker can monitor organ stiffness and detect subtle changes that signal disease progression. The device has been shown to identify early signs of acute liver failure in rats and may one day help doctors diagnose internal organ failure more effectively.
Researchers identified mechanisms that cause ponatinib to harm the heart and found a promising treatment that could reverse this process. The treatment protects heart cells without diminishing the tumor-fighting efficacy of the drug.
A recent study found that only half of hookah packages included the required nicotine warnings, two years after federal regulation was implemented. The study led by Boston University School of Public Health researcher Dr. Jennifer Ross highlights the importance of warning labels in communicating health risks to consumers.
Researchers found that combining SORA with FGF21 increases the sensitivity of SORA to HCC cells under hypoxia conditions. This combination therapy promotes apoptosis and inhibits tumor growth through the PI3K/AKT pathway, suggesting a new potential treatment approach for advanced liver cancer.
The Vilcek Foundation has awarded $250,000 to four immigrant scientists for their pioneering work in biomedical science. Luciano Marraffini, Gerta Hoxhaj, Tomasz Nowakowski, and Takanori Takebe are recognized for their contributions to cancer research, pluripotent stem cells, and CRISPR-Cas systems.
Researchers found that tumors with preexisting immune cell networks were most primed to respond to adoptive T cell therapy, and patients whose tumors featured such networks responded best to treatment. The study provides a step towards identifying patients who are likely to benefit from personalized immunotherapies.
Korea University researchers found that perioperative radiotherapy significantly improves survival rates among HCC patients at high risk of recurrence. The study suggests that radiotherapy can reduce recurrence and improve survival in these patients, providing a significant adjuvant treatment option.
A study of 2.9 million Korean adults found that quitting smoking at any age reduced the risk of cancer, particularly lung cancer, after 10 years. Early cessation before middle age led to a substantial risk reduction in lung cancer.
Researchers at Michigan State University have found a potential breakthrough in treating glioblastoma by targeting an acid sensor on cancer cell membranes. The compound OGM showed remarkable ability to kill glioblastoma cells while leaving normal cells unharmed.
Advanced lung cancer patients treated with combination chemoradiotherapy have a higher incidence of mixed infections and elevated inflammatory markers. Antibiotic therapy is recommended to ensure coverage of gram-negative bacilli pathogens.
Researchers mapped changes in tumor-related bacteria to uncover potential strategies to combat the rise of young-onset colorectal cancer. Unique bacterial signatures were found in tumors from younger patients, including Akkermansia and Bacteroides, which are more likely to have left-sided, rectal, and advanced stage tumors.
Scientists have imaged microtubule formation in unprecedented detail, revealing a complex process that involves the gamma-tubulin ring complex and a newly-discovered latch mechanism. The findings hold promise for developing targeted therapies for various diseases, including cancer and neurodevelopmental disorders.
A team of scientists has developed a new type of anticancer agent targeting cancer stem cells, which are difficult to eradicate. The compound, called Ru1, promotes a decrease in the expression of genes necessary for mitochondrial respiration, causing cancerous cells to lose their potential.
Researchers developed a new chip that can detect cancer cells in blood samples, enabling clinicians to adapt treatments and improve outcomes for patients with lung cancer. The device traps and concentrates tiny numbers of cancer cells, allowing for regular monitoring of treatment effectiveness.
Researchers have developed an AI-driven test that accurately diagnoses ovarian cancer in women clinically classified as normal, improving detection of early-stage disease. The test uses machine learning and blood metabolite information to assign a probability of disease presence or absence, offering a more clinically informative approach.
A new CRISPR-based technology, TRED-I, has been developed to increase visibility of cancer cells to the immune system by augmenting MHC class I molecules. This technology has shown promising results in animal cancer models, reducing tumor sizes and enhancing treatment efficacy when used with existing immunotherapy.
Researchers discovered that cisplatin chemotherapy enhances the immune system's ability to fight bladder cancer by modulating the immune response and damaging DNA in cancer cells. This approach may lead to durable disease control in a subset of patients with metastatic bladder cancer.
Researchers found that the loss of Bmal1 reduces melanoma tumor growth, contrary to expectations. The study also uncovered mechanisms of tumor suppression and resistance to immunotherapy, suggesting a contextually variable role for the circadian clock in cancer.
Senescent tumour cells generated by chemotherapy can create an environment that helps tumour cells escape treatment. Eliminating these cells with immunotherapy boosts the effectiveness of chemotherapy.
Researchers developed an mRNA therapeutic that combats ovarian cancer by producing functional p53 protein, shrinking and killing tumors. The treatment is effective against metastases and has shown promise in preclinical studies.
A recent survey found that 51% of Americans are unaware that heart disease is the leading cause of death in the US. This lack of knowledge can be deadly, with nearly half of adults having some form of cardiovascular disease.
A study of 157,000 participants found that those with recent weight loss were more likely to be diagnosed with cancer within the next 12 months. Cancer of the upper gastrointestinal tract was most commonly associated with recent weight loss.
Stacyann Bailey studies how cancer treatment affects bones, hoping to prevent fractures and improve patient outcomes. Up to 50% of patients with metastatic bone disease develop fractures due to treatment, making her work crucial for their quality of life.
Researchers develop compound that reduces size of kidney cysts and improves kidney function in mouse models of ADPKD. The compound, originally designed to treat cancer, works by exploiting kidney cyst cells' vulnerability to oxidative stress.
Researchers at State University of Campinas discovered genes favoring colossal growth in whales also inhibit cancer development. The study found that certain regulatory regions influence both size and cancer suppression, offering new insights into the evolution of cetacean gigantism.
Researchers have revealed CD4+ T cells can work effectively on their own to control melanoma, challenging conventional understanding. Harnessing their potential therapeutically holds great promise for improving current cancer immunotherapies.
A groundbreaking study uses machine learning to predict treatment resistance in cervical cancer by analyzing genetic mutations. The algorithm identified molecular assemblies driving treatment resistance and pinpointed tumors most susceptible to therapy, resulting in improved patient outcomes.
A study has generated a detailed portrait of brain tumor blood vessels, revealing how they support cancer growth and immune evasion. Researchers identified a potential target, CD276, and showed that its inhibition extends survival in mice with breast cancer brain metastases.
Researchers developed intravenous priming agents that increase the recovery and detection of tumor-derived genetic fragments in liquid biopsies. In mouse models, these agents increased sensitivity for detecting small tumors from 10% to 75%. The approach may boost the sensitivity of liquid biopsies in cancer care and beyond.
Scientists have developed two injectable priming agents to improve liquid biopsy performance by slowing down the clearance of circulating tumor DNA from the body. In mouse studies, these agents increased circulating tumor DNA levels by more than 10-fold, improving the sensitivity of detecting cancer in mice with low tumor burden.
A new diagnostic kit allows dentists to screen for oral squamous cell carcinoma with a simple brush biopsy, detecting genetic signals of the disease with over 90% accuracy. The non-invasive test is less complicated than surgical biopsies and can be performed in under a minute without numbing required.
Researchers discuss reductive carboxylation of glutamine as a potential target in acute myeloid leukemia (AML), an aggressive cancer with poor patient outcomes. The approach aims to weaken tumor cell survival mechanisms, potentially leading to novel therapies and improved patient outcomes.
A new study conducted by Qianwei Liu and colleagues found that parents of children with cancer are more likely to attempt suicide during the first years after diagnosis. The risk is higher for parents whose child was diagnosed under 18 or had an aggressive form of cancer.
Researchers have shown that combining poverty with chronic inflammation worsens health outcomes, increasing heart disease and cancer mortality rates. The study analyzed data from nearly 95 million adults and found a synergistic effect of poverty and inflammation on mortality.
Despite declining overall US cancer mortality rates, substantial racial disparities persisted for many common cancers, including breast and colorectal cancer. Structural racism, medical mistrust, and health care access inequities contribute to these disparities.
A study of nearly 15,000 adults with non–small cell lung cancer found that Medicaid expansion decreased postoperative mortality within 30 and 90 days after hospital discharge. This suggests that expanded Medicaid coverage may improve cancer outcomes and access to care for this population.